I. Brar

发表

A Comparison of Factors Associated With Prevalent Diabetes Mellitus Among HIV-Infected Antiretroviral-Naive Individuals Versus Individuals in the National Health and Nutritional Examination Survey Cohort

Avis J. Thomas, J. Absalon, J. Shuter, 2007, Journal of acquired immune deficiency syndromes.

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study.

J. van Lunzen, M. Cavassini, C. Orkin, 2016, The Lancet. Infectious diseases.

CURB-65 and SMRT-CO in the prediction of early transfers to the intensive care unit among patients with community-acquired pneumonia initially admitted to a general ward.

M. Huaman, S. Kaatz, S. Hegab, 2011, Journal of hospital medicine.

Antimicrobial stewardship: Strategies for a global response

M. Zervos, J. Zervos, I. Brar, 2014 .

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

Rebecca M. Baker, Phuong Thi Tuyet Nguyen, Carol L. Eyler, 2021, The Lancet Infectious Diseases.

Cardiac sequelae of novel coronavirus disease 2019 (COVID-19): a clinical case series

Z. Demertzis, I. Brar, R. Fadel, 2020, European heart journal. Case reports.

HCV Enters the Twenty-First Century

N. Markowitz, D. Baxa, I. Brar, 2013, Current Infectious Disease Reports.

Descriptive Analysis of Patients Living With HIV Affected by COVID-19

N. Markowitz, N. Yared, I. Brar, 2020, Journal of acquired immune deficiency syndromes.

Rapid Reorganization of an Academic Infectious Diseases Program During the COVID-19 Pandemic in Detroit: A Novel Unit-Based Group Rounding Model

P. Bhargava, L. Kaljee, M. Zervos, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Progression to Critical Illness and Death in Patients With Breakthrough Hospitalizations

M. Ramesh, G. Alangaden, T. Singh, 2022, Open forum infectious diseases.

Central nervous system manifestations in human immunodeficiency virus patients in the antiretroviral therapy era - Scenario from a developing country

J. Pandian, A. Oberoi, M. John, 2015 .

Disseminated Strongyloidiasis: Breaking Brain Barriers

J. Pandian, M. Kate, A. Oberoi, 2019, Annals of Indian Academy of Neurology.

Progressive multifocal leukoencephalopathy and idiopathic CD4+lymphocytopenia: a case report and review of reported cases.

D. Nafziger, S. Haider, J. Fogle, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19

P. Bhargava, J. gardner-Gray, P. Kilgore, 2020, International Journal of Infectious Diseases.

Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy: A Randomized Phase 2 Study

P. Sax, A. Zolopa, F. Post, 2014, Journal of acquired immune deficiency syndromes.

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

D. Podzamczer, K. White, J. Gallant, 2017, The Lancet.

Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy.

D. Musher, E. Graviss, Seth B. Furgeson, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit

M. Zervos, G. Alangaden, M. Ramesh, 2020, JAMA network open.

Intravenous ganciclovir consistently induces remission of persistent Epstein-Barr encephalitis in an HIV-1-infected patient.

P. Mitsias, A. Katramados, I. Brar, 2007, AIDS.

Adult-onset Still Disease Masqueraded as Sepsis

I. Brar, J. Aguilar, Giancarlo Diaz Zamora, 2010 .

Health Disparities in Hepatitis C Screening and Linkage to Care at an Integrated Health System in Southeast Michigan

Kimberly Baker-Genaw, I. Brar, Kassem Bourgi, 2016, PloS one.

Evaluating the Impact of Substance Use Disorder Resources on Outcomes of Persons Who Inject Drugs with Infections

S. Davis, R. Kenney, I. Brar, 2022, Journal of addiction medicine.

Unmasking lymphoma immune reconstitution inflammatory syndrome in a patient with pyrexia of unknown origin: a case report.

B. Venkatesulu, M. Scott, I. Brar, 2020, Journal of the Egyptian National Cancer Institute.

Disseminated Cryptococcal Disease in Liver Cirrhosis

I. Brar, T. P. Acosta, 2019 .

Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections

G. Alangaden, Rafa Khansa, R. Tibbetts, 2022, Open forum infectious diseases.

The seroprevalence of COVID-19 in patients living with HIV in metropolitan Detroit

N. Markowitz, N. Yared, Sean Yaphe, 2022, International journal of STD & AIDS.

Clinical Prediction Rule for Respiratory Isolation of Patients With Suspected Pulmonary Tuberculosis

James J. Yang, N. Markowitz, I. Brar, 2009 .

Mechanical Ventilation and Coronavirus Disease 2019: A Case-Control Analysis of Clinical Characteristics, Lung Mechanics, and Mortality

Krishnakumari A. Modi, D. Ouellette, A. Scott, 2021, Critical care explorations.

Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study

M. Saag, M. Ramgopal, D. Brainard, 2021, Journal of acquired immune deficiency syndromes.

Latent infection as a source of disseminated disease caused by organisms of the Mycobacterium avium complex in simian immunodeficiency virus-infected rhesus macaques.

J. Maslow, Gary Smith, P. Didier, 2003, The Journal of infectious diseases.

Occurrence of the S230R integrase strand inhibitor mutation in a treatment-naïve individual case report

N. Markowitz, I. Brar, A. Golembieski, 2020, Medicine.

Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV‐infected patients: a retrospective cohort study

U. Iloeje, M. Pladevall, J. Lafata, 2005, HIV medicine.

The Impact of Sociodemographic Factors, Comorbidities and Physiologic Response on 30-day Mortality in COVID-19 Patients in Metropolitan Detroit

M. Zervos, G. Alangaden, A. Tang, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.

D. Podzamczer, H. Stellbrink, D. Ward, 2018, The lancet. HIV.

Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy

M. Johnson, B. Grund, R. Colebunders, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Late presentation and transmitted drug resistance mutations in new HIV-1 diagnoses in Detroit.

N. Markowitz, M. Huaman, D. Baxa, 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

SARS‐CoV‐2 neutralizing antibodies for COVID‐19: Outcomes for bamlanivimab versus bamlanivimab‐etesevimab combination in a racially diverse cohort of patients with significant comorbidities

M. Ramesh, G. Alangaden, I. Brar, 2022, Journal of clinical pharmacy and therapeutics.

Outcomes Associated with SARS-CoV-2 Reinfection in Individuals with Natural and Hybrid Immunity

G. Alangaden, Kunj G. Patel, I. Brar, 2023, Journal of infection and public health.

Outcomes associated with SARS-CoV-2 reinfection in individuals with natural and hybrid immunity

G. Alangaden, Kunj G. Patel, I. Brar, 2023, Journal of infection and public health.

Papillomatous Anogenital Lesions in a Patient With Human Immunodeficiency Virus

A. Boucher, Dayoung Ko, I. Brar, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epstein-Barr Virus Induced Fulminant Hepatitis in a Young Immunocompetent Male: Case Report and Literature Review

M. Huaman, I. Brar, J. Aguilar, 2009 .

Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) Fixed-Dose Combination (FDC) Compared With Ritonavir-Boosted Atazanavir (ATV/r) Plus Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) in Treatment-Naive Women With Human Immunodeficiency Virus (HIV)-1 Infection (ARIA Study): Analyses by

Kimberly Smith, M. Aboud, B. Wynne, 2016 .

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

T. Harrer, A. Winston, E. Harrer, 2023, Scientific Reports.

D. Podzamczer, H. Stellbrink, D. Ward, 2018, The lancet. HIV.